We performed a randomised , double-blind , placebo-controlled study , examining the effect of 1-year treatment with allopurinol ( 300mg daily ) , on change in CBP , arterial stiffness and CIMT progression at 1year and change in endothelial function and circulating inflammatory markers at 6months .